SPY311.36-0.82 -0.26%
DIA263.33+0.16 0.06%
IXIC9,615.81-67.10 -0.69%
News
DARE
--
0.00%
--
Daré Bioscience Announces Participation in BIO Digital 2020
Daré Bioscience, Inc. (DARE), a leader in women’s health innovation, today announced that the company will participate in the BIO International Convention, which will be held in a new, virtual event format for 2020, known as BIO Digital, from June 8-12, 2020.
GlobeNewswire · 19h ago
Dare Bioscience Files Prospectus Supplement Related To Offering Of 7.5M Shares Of Common Stock
Benzinga · 05/20 10:13
Edited Transcript of DARE earnings conference call or presentation 14-May-20 8:30pm GMT
Q1 2020 Dare Bioscience Inc Earnings Call
Thomson Reuters StreetEvents · 05/17 19:02
Dare Bioscience Inc Files Prospectus Relates To Possible Resale From Time To Time Of Up To 5M Shares Of Common Stockby Selling Stockholders
-Reuters
Reuters · 05/15 20:23
Daré Bioscience, Inc. (DARE) CEO Sabrina Martucci Johnson on Q1 2020 Results - Earnings Call Transcript
Seeking Alpha - Transcript · 05/15 02:49
Daré Bioscience Reports First Quarter 2020 Financial Results and Provides Company Update
GlobeNewswire · 05/14 13:00
Dare Bioscience Q1 EPS $(0.180) Beats $(0.290) Estimate
Dare Bioscience (NASDAQ:DARE) reported quarterly losses of $(0.180) per share which beat the analyst consensus estimate of $(0.290) by 37.93 percent. This is a 33.33 percent increase over losses of $(0.270) per share
Benzinga · 05/14 12:11
Dare Biosciences Reports Formation Of Strategic Partnership With Health Decisions To Accelerate Development Of Co.'s Novel Pipeline Of Women's Health Programs
Daré Bioscience, Inc. (NASDAQ:DARE), a leader in women’s health innovation, and Health Decisions, Inc., a full-service contract research organization (CRO) specializing in women’s health clinical
Benzinga · 05/11 12:14
Daré Bioscience and Health Decisions Form Strategic Partnership to Accelerate the Development of Daré’s Novel Pipeline of Women’s Health Programs
Daré Bioscience, Inc. (DARE), a leader in women’s health innovation, and Health Decisions, Inc., a full-service contract research organization (CRO) specializing in women’s health clinical research and diagnostic development, today announced that the companies
GlobeNewswire · 05/11 12:00
The Week Ahead In Biotech: Virtual Conference Presentations, Clovis PDUFA Date In The Spotlight
The smid-cap biotech earnings deluge hit Wall Street in the week ended May 9, positively impacting the stocks in the sector. The iShares NASDAQ Biotechnology Index (NASDAQ: IBB) gained about 6% for the week.
Benzinga · 05/10 19:40
Daré Bioscience to Host First Quarter 2020 Financial Results and Company Update Conference Call and Webcast on May 14, 2020
GlobeNewswire · 05/07 13:00
Daré Bioscience files for 7.5M common shares
Daré Bioscience (NASDAQ:DARE) has filed a prospectus for a 7.5M common shares from stockholders. This filing does not necessarily indicate that a sale has
seekingalpha · 05/02 14:43
BBBY, DVAX among premarket gainers
Seeking Alpha - Article · 04/28 13:22
Daré Bioscience CEO to Participate in Maxim Group’s Infectious Disease Virtual Conference
Daré Bioscience, Inc.(DARE), a leader in women’s health innovation, today announced that Sabrina Martucci Johnson, President and Chief Executive Officer, will participate in a panel discussion during the Infectious Disease Virtual Conference presented by Maxim
GlobeNewswire · 04/28 12:00
Wells softens view on Edwards Lifesciences in premarket analyst action
Seeking Alpha - Article · 04/28 11:32
Brookline Capital Initiates Coverage On Dare Bioscience with Buy Rating, Announces Price Target to $7.5
Brookline Capital analyst Sally Yanchus initiates coverage on Dare Bioscience (NASDAQ:DARE) with a Buy rating and announces Price Target to $7.5.
Benzinga · 04/28 09:59
Dare Biosciences Shares Up 26% After Hours; Hearing Boutique Research Shop Brookline Capital Has Initiated Stock With Buy Rating, $7.50 Price Target
Benzinga · 04/27 20:28
Daré Bioscience Announces Common Stock Purchase Agreement for up to $15 Million with Lincoln Park Capital Fund, LLC
GlobeNewswire · 04/23 13:00
Daré Bio launches stock purchase agreement for $15M
Seeking Alpha - Article · 04/23 12:54
Dare Bioscience Reports $15M Common Stock Purchase Deal With Lincoln Park Capital
Benzinga · 04/23 12:12